All In Biotech

Drug Trial Radar · NCT06334133

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

Cadisegliatin as Adjunctive Therapy in Type 1 Diabetes: A 26-Week Double-Blind, Randomized, Placebo-Controlled Phase 3 Study

Last checked: Nov 19, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 150 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Jun 14, 2024

Primary completion

Apr 2027

Study completion May 2027

Sponsor

Lead sponsor
vTv TherapeuticsIndustry
Sponsor type
Industry
First posted
Mar 27, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3 trial of cadisegliatin as adjunctive therapy to insulin in participants with Type 1 Diabetes Mellitus.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

  • Cadisegliatin 800 mg QDDrug

    Cadisegliatin is an orally bioavailable small-molecule glucokinase activator; adjunctive therapy to insulin.

  • Cadisegliatin 800 mg BIDDrug

    Cadisegliatin is an orally bioavailable small-molecule glucokinase activator; adjunctive therapy to insulin.

  • PlaceboDrug

    Placebo (insulin alone)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in incidence of Level 2 or Level 3 hypoglycemiaTime frame: 26 weeks

Locations

48 sites in 2 countries. Site status is shown where the registry gives one.

  • Scottsdale Clinical Trials

    Scottsdale, Arizona

  • Baptist Health Center for Clinical Research

    Little Rock, Arkansas

  • John Muir Physician Network Clinical Research Center

    Concord, California

  • Amicis Research Center

    Granada Hills, California

  • AME Clinical Research

    Huntington Beach, California

  • Scripps Whittier Diabetes Institute

    La Jolla, California

  • IMAX Clinical Trials

    La Palma, California

  • Paradigm Clinical Research - Modesto

    Modesto, California

  • Paradigm Clinical Research Centers LLC

    San Diego, California

  • Acclaim Clinical Research

    San Diego, California

  • The Lundquist Institute

    Torrance, California

  • Focus Clinical Research

    West Hills, California

  • Denver Endocrinology Diabetes and Thyroid Center

    Englewood, Colorado

  • BayCare Health Systems

    Clearwater, Florida

  • Metabolic Research Institute, Inc

    West Palm Beach, Florida

  • Atlanta Diabetes Associates

    Atlanta, Georgia

  • Centricity Research - Columbus

    Columbus, Georgia

  • The Jones Center Clinical Research, LLC

    Macon, Georgia

  • DM Clinical Research

    Indianapolis, Indiana

  • Accellacare - McFarland

    Ames, Iowa

  • Iowa Diabetes and Endocrinology Research Center

    West Des Moines, Iowa

  • Johnson County Clin-Trials, LLC

    Lenexa, Kansas

  • MedStar Good Samaritan Hospital

    Baltimore, Maryland

  • Massachusetts General Hospital Diabetes Research Center

    Boston, Massachusetts

  • Profound Research LLC

    Farmington Hills, Michigan

  • Excel Clinical Research

    Las Vegas, Nevada

  • Palm Research Center

    Las Vegas, Nevada

  • Vector Clinical Trials

    Reno, Nevada

  • AMC Community Endocrinology

    Albany, New York

  • Jacobi Medical Center

    The Bronx, New York

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • Javarra Inc.

    Charlotte, North Carolina

  • Physician's East PA

    Greenville, North Carolina

  • Centricity Research Morehead City Multispecialty

    Morehead City, North Carolina

  • Diabetes & Endocrinology Associates of Stark County, Inc

    Canton, Ohio

  • Velocity Clinical Research

    Medford, Oregon

  • University of Pennsylvania Perelman Center for Advanced Medicine

    Philadelphia, Pennsylvania

  • Circle Clinical Research

    Sioux Falls, South Dakota

  • Texas Diabetes and Endocrinology, P.A

    Austin, Texas

  • Velocity Clinical Research - Dallas

    Dallas, Texas

Showing 40 of 48 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.